BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
BIOADAPTIVES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026
- Market cap
- $478.03K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Bioadaptives has not reported a dividend
No dividend per share appears in Bioadaptives's annual filings since fiscal 2013.